South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Find Industry reports, Company profiles
ReportLinker and Market Statistics

>> Get this Report Now by email!

South Africa In Vitro Diagnostics Investment Opportunities, Analysis
and Forecasts to 2015
Published on September 2009

Report Summary

South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to South Africa In vitro diagnostic dvices market. It also
offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news,
financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in South Africa

Scope

- The report provides information on the In vitro diagnostics market in South Africa, broken down into detailed categories and
segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test
Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and
Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in South Africa.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are
launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in
the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015 Page 1/11


Table of Content

1 Table of Contents 2

1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About' 13
3 Definitions of the Markets Covered in the Report 14
3.1 In Vitro Diagnostics 14
3.2 Clinical Chemistry 14
3.2.1 Clinical Chemistry Rapid Tests & POC 14
3.2.2 Clinical Chemisty Analyzers 14
3.2.3 Electrolyte Chemistry Reagents 14
3.2.4 Enzyme Chemistry Reagents 15
3.2.5 Metabolite Chemistry Reagents 15
3.2.6 Urine Analysis 15
3.3 Genetic Testing 15
3.3.1 Acquired Gene or Chromosome Alterations 15
3.3.2 Inborn Gene or Chromosome Alterations 15
3.3.3 Other Genetic Tests 15
3.4 Haematology 15
3.4.1 Haematology Analyzers 15
3.4.2 Haematology Cell Counters 16
3.4.3 Haematology Rapid Tests 16
3.4.4 Haematology Reagents 16
3.4.5 Haemostasis 16
3.4.6 Immunohaematology 17
3.5 Histology And Cytology 17
3.5.1 Cytology 17
3.5.2 Histology 17
3.6 Immuno Chemistry 18
3.6.1 Disease Specific Immunochemistry 18
3.6.2 Drug Related Testing 18
3.6.3 Endocrinology Tests 19
3.6.4 Immunochemistry Analyzers 19
3.6.5 Immunochemistry Rapid Tests 19
3.6.6 Organ Function Assays 19
3.6.7 Specific Proteins 20
3.7 Infectious Immunology 20
3.7.1 Bacteriology 20
3.7.2 Hepatitis Viruses 20
3.7.3 Other Virology 20
3.7.4 Retroviruses 20
3.8 Microbiology Culture 20
3.8.1 Bacterial Identification & Susceptibility Testing 20
3.8.2 Blood Culture 20
3.8.3 Immunological Culture Identification 20



3.8.4 Microbiology Analyzers 20
3.8.5 Mycobacteria Culture 21
3.8.6 Mycology Culture 21
3.8.7 Parasitology Culture 21
4 Healthcare Sector Review 22
4.1 Proposed Health System in South Africa 22
5 Regulation System 25
5.1 Medical Equipment Regulation System 25
5.2 Regulation of Electromagnetic Medical Devices 25
5.3 Future Outlook 28
6 Pricing and Reimbursement 29
6.1 Reimbursement 29
6.2 Pricing 29
7 Distribution Structure 30
8 In Vitro Diagnostics In South Africa 31
8.1 In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), 2000-2015 31
8.2 In Vitro Diagnostics, South Africa, Company Share (2007-2008) 37
9 Clinical Chemistry In South Africa 38
9.1 Clinical Chemistry Overall Revenue (2000-2015) 38
9.1.1 Clinical Chemistry Analyzers Revenue (2000-2015) 42
9.1.2 Urine Analysis Revenue (2000-2015) 44
9.2 Clinical Chemistry Distribution Share (2007-2008) 46
9.3 Clinical Chemistry, South Africa, Company Share (2007-2008) 47
10 Genetic Testing In South Africa 48
10.1 Genetic Testing Overall Revenue (2000-2015) 48
10.2 Genetic Testing Distribution Share (2007-2008) 50
10.3 Genetic Testing, South Africa, Company Share (2007-2008) 51
11 Haematology In South Africa 52
11.1 Haematology Overall Revenue (2000-2015) 52
11.1.1 Haematology Reagents Revenue (2000-2015) 56
11.1.2 Immunohaematology Revenue (2000-2015) 58
11.1.3 Haemostasis Revenue (2000-2015) 60
11.1.4 Haematology Rapid Tests Revenue (2000-2015) 64
11.1.5 Haematology Cell Counters Revenue (2000-2015) 66
11.2 Haematology Distribution Share (2007-2008) 68
11.3 Haematology, South Africa, Company Share (2007-2008) 69
12 Histology and Cytology In South Africa 70
12.1 Histology and Cytology Overall Revenue (2000-2015) 70
12.1.1 Histology Revenue (2000-2015) 72
12.2 Histology And Cytology Distribution Share (2007-2008) 74
12.3 Histology and Cytology, South Africa, Company Share (2007-2008) 75
13 Immuno Chemistry In South Africa 76
13.1 Immuno Chemistry Overall Revenue (2000-2015) 76
13.1.1 Disease Specific Immunochemistry Revenue (2000-2015) 80
13.1.2 Drug Related Testing Revenue (2000-2015) 84
13.1.3 Endocrinology Tests Revenue (2000-2015) 86
13.1.4 Immunochemistry Analyzers Revenue (2000-2015) 88
13.2 Immuno Chemistry Distribution Share (2007-2008) 92
13.3 Immuno Chemistry, South Africa, Company Share (2007-2008) 93
14 Infectious Immunology In South Africa 95



14.1 Infectious Immunology Overall Revenue (2000-2015) 95
14.2 Infectious Immunology Distribution Share (2007-2008) 99
14.3 Infectious Immunology, South Africa, Company Share (2007-2008) 100
15 Microbiology Culture In South Africa 102
15.1 Microbiology Culture Overall Revenue (2000-2015) 102
15.1.1 Microbiology Analyzers Revenue (2000-2015) 106
15.2 Microbiology Culture Distribution Share (2007-2008) 108
15.3 Microbiology Culture, South Africa, Company Share (2007-2008) 109
16 Overview of Key Companies in South Africa In Vitro Diagnostics Market 111
16.1 Ventana Medical Systems, Inc. 111
16.1.1 Company Overview 111
16.2 Sysmex Corporation 111
16.2.2 Sysmex Corporation Pipeline Products 111
16.3 Siemens Healthcare 113
16.4 Qiagen N.V. 113
16.4.2 Qiagen N.V. Pipeline Products 114
16.5 Phadia AB 116
16.5.2 Phadia AB Pipeline Products 116
16.6 Ortho-Clinical Diagnostics Inc. 118
16.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products 118
16.7 OLYMPUS CORPORATION 120
16.8 Inverness Medical Innovations, Inc. 120
16.8.2 Inverness Medical Innovations, Inc. Pipeline Products 121
16.9 Hologic, Inc. 123
16.9.2 Hologic, Inc. Pipeline Products 123
16.10 Gen-Probe Incorporated 126
16.10.2 Gen-Probe Incorporated Pipeline Products 126
16.11 F. Hoffmann-La Roche Ltd. 129
16.12 DiaSorin S.p.A 129
16.12.2 DiaSorin S.p.A Pipeline Products 130
16.13 Dade Behring Holdings, Inc. 131
16.14 Bio-Rad Laboratories, Inc. 131
16.15 bioMerieux S.A. 132
16.16 Becton, Dickinson and Company 132
16.16.2 Becton, Dickinson and Company Pipeline Products 133



16.17 Beckman Coulter, Inc. 136
16.17.2 Beckman Coulter, Inc. Pipeline Products 137
16.18 Abbott Laboratories 140
16.18.2 Abbott Laboratories Pipeline Products 140
17 Financial Deals Landscape 141
17.1 Acquisition 141
17.1.1 Inverness Medical Innovations Acquires Vision Biotech 141
17.1.2 Inverness Medical Innovations Acquires Global Diagnostics 142
18 Appendix 143
18.1 Global Markets Direct Research Methodology 143
18.2 Secondary Research 144
18.3 Primary Research 144
18.4 Models 145
18.5 Forecasts 145
18.6 Expert Panel Validation 145
18.7 Currency Conversion 146
18.8 Contact Us 147
18.9 Disclaimer 147

1.1 List of Tables

Table 1: Healthcare Statistics, South Africa, 2000-2008 23
Table 2: Healthcare Expenditure, South Africa, 2000-2008 23
Table 3: South Africa Trade Statistics, 2004-2008 24
Table 4: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), 2000-2015 31
Table 5: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2000-2015 32
Table 6: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), Historic, 2000-2008 34
Table 7: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), Forecast, 2008-2015 36
Table 8: In Vitro Diagnostics, South Africa, Company Share by Revenue ($ mn), 2007-2008 37
Table 9: Clinical Chemistry, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 39
Table 10: Clinical Chemistry, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 41
Table 11: Clinical Chemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 42
Table 12: Clinical Chemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 43
Table 13: Urine Analysis, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 44
Table 14: Urine Analysis, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 45
Table 15: Clinical Chemistry, South Africa, Distribution Share by Revenue ($mn), 2007-2008 46
Table 16: Clinical Chemistry, South Africa, Company Share by Revenue ($ mn), 2007-2008 47
Table 17: Genetic Testing, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Table 18: Genetic Testing, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 19: Genetic Testing, South Africa, Distribution Share by Revenue ($mn), 2007-2008 50
Table 20: Genetic Testing, South Africa, Company Share by Revenue ($ mn), 2007-2008 51
Table 21: Haematology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 53
Table 22: Haematology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 55
Table 23: Haematology Reagents, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Table 24: Haematology Reagents, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Table 25: Immunohaematology, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Table 26: Immunohaematology, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 59
Table 27: Haemostasis, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61



Table 28: Haemostasis, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 29: Haematology Rapid Tests, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 64
Table 30: Haematology Rapid Tests, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 65
Table 31: Haematology Cell Counters, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 66
Table 32: Haematology Cell Counters, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 33: Haematology, South Africa, Distribution Share by Revenue ($mn), 2007-2008 68
Table 34: Haematology, South Africa, Company Share by Revenue ($ mn), 2007-2008 69
Table 35: Histology And Cytology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 70
Table 36: Histology And Cytology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 71
Table 37: Histology, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 72
Table 38: Histology, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 73
Table 39: Histology And Cytology, South Africa, Distribution Share by Revenue ($mn), 2007-2008 74
Table 40: Histology And Cytology, South Africa, Company Share by Revenue ($ mn), 2007-2008 75
Table 41: Immuno Chemistry, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 77
Table 42: Immuno Chemistry, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 79
Table 43: Disease Specific Immunochemistry, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Table 44: Disease Specific Immunochemistry, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 83
Table 45: Drug Related Testing, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 84
Table 46: Drug Related Testing, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 85
Table 47: Endocrinology Tests, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 86
Table 48: Endocrinology Tests, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 87
Table 49: Immunochemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 50: Immunochemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 91
Table 51: Immuno Chemistry, South Africa, Distribution Share by Revenue ($mn), 2007-2008 92
Table 52: Immuno Chemistry, South Africa, Company Share by Revenue ($ mn), 2007-2008 94
Table 53: Infectious Immunology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 96
Table 54: Infectious Immunology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 98
Table 55: Infectious Immunology, South Africa, Distribution Share by Revenue ($mn), 2007-2008 99
Table 56: Infectious Immunology, South Africa, Company Share by Revenue ($ mn), 2007-2008 101
Table 57: Microbiology Culture, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 103
Table 58: Microbiology Culture, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 105
Table 59: Microbiology Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 106
Table 60: Microbiology Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Table 61: Microbiology Culture, South Africa, Distribution Share by Revenue ($mn), 2007-2008 108
Table 62: Microbiology Culture, South Africa, Company Share by Revenue ($ mn), 2007-2008 110
Table 63: Sysmex Corporation Pipeline Products by Equipment Type 111
Table 64: Sysmex Corporation Pipeline Products By Development Stage 111
Table 65: Sysmex Corporation Pipeline Products By Therapy Area 112
Table 66: Sysmex Corporation Pipeline Products By News Summary 112
Table 67: Qiagen N.V. Pipeline Products by Equipment Type 114
Table 68: Qiagen N.V. Pipeline Products By Development Stage 114
Table 69: Qiagen N.V. Pipeline Products By Therapy Area 115
Table 70: Qiagen N.V. Pipeline Products By News Summary 115
Table 71: Phadia AB Pipeline Products by Equipment Type 116
Table 72: Phadia AB Pipeline Products By Development Stage 116
Table 73: Phadia AB Pipeline Products By Therapy Area 117
Table 74: Phadia AB Pipeline Products By News Summary 117
Table 75: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 118
Table 76: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 119
Table 77: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 119



Table 78: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 121
Table 79: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 121
Table 80: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 122
Table 81: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 122
Table 82: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 122
Table 83: Hologic, Inc. Pipeline Products by Equipment Type 123
Table 84: Hologic, Inc. Pipeline Products By Development Stage 124
Table 85: Hologic, Inc. Pipeline Products By Therapy Area 124
Table 86: Hologic, Inc. Pipeline Products By Clinical Trials 124
Table 87: Hologic, Inc. Pipeline Products By News Summary 125
Table 88: Gen-Probe Incorporated Pipeline Products by Equipment Type 126
Table 89: Gen-Probe Incorporated Pipeline Products By Development Stage 127
Table 90: Gen-Probe Incorporated Pipeline Products By Therapy Area 127
Table 91: Gen-Probe Incorporated Pipeline Products By Clinical Trials 127
Table 92: Gen-Probe Incorporated Pipeline Products By News Summary 128
Table 93: DiaSorin S.p.A Pipeline Products by Equipment Type 130
Table 94: DiaSorin S.p.A Pipeline Products By Development Stage 130
Table 95: DiaSorin S.p.A Pipeline Products By Therapy Area 130
Table 96: Becton, Dickinson and Company Pipeline Products by Equipment Type 133
Table 97: Becton, Dickinson and Company Pipeline Products By Development Stage 134
Table 98: Becton, Dickinson and Company Pipeline Products By Therapy Area 134
Table 99: Becton, Dickinson and Company Pipeline Products By Clinical Trials 135
Table 100: Becton, Dickinson and Company Pipeline Products By News Summary 135
Table 101: Beckman Coulter, Inc. Pipeline Products by Equipment Type 137
Table 102: Beckman Coulter, Inc. Pipeline Products By Development Stage 138
Table 103: Beckman Coulter, Inc. Pipeline Products By Therapy Area 139
Table 104: Beckman Coulter, Inc. Pipeline Products By News Summary 139
Table 105: Abbott Laboratories Pipeline Products by Equipment Type 140
Table 106: Abbott Laboratories Pipeline Products By Development Stage 140
Table 107: Abbott Laboratories Pipeline Products By Therapy Area 140
Table 108: Inverness Medical Innovations Acquires Vision Biotech 141
Table 109: Inverness Medical Innovations Acquires Global Diagnostics 142
Table 110: USD to Local Currency, Average Exchange Rate 2008 146

1.2 List of Figures

Figure 1: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), 2000-2015 31
Figure 2: In Vitro Diagnostics, South Africa, Cross-Category Analysis, 2000-2015 32
Figure 3: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), Historic, 2000-2008 33
Figure 4: In Vitro Diagnostics, South Africa, Overall Revenue ($ mn), Forecast, 2008-2015 35
Figure 5: In Vitro Diagnostics, South Africa, Company Share (%), 2008 37
Figure 6: Clinical Chemistry, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 38
Figure 7: Clinical Chemistry, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 40
Figure 8: Clinical Chemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 42
Figure 9: Clinical Chemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 43
Figure 10: Urine Analysis, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 44
Figure 11: Urine Analysis, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 45
Figure 12: Clinical Chemistry, South Africa, Company Share (%), 2008 47
Figure 13: Genetic Testing, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Figure 14: Genetic Testing, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 49



Figure 15: Genetic Testing, South Africa, Company Share (%), 2008 51
Figure 16: Haematology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 52
Figure 17: Haematology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 54
Figure 18: Haematology Reagents, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 56
Figure 19: Haematology Reagents, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 57
Figure 20: Immunohaematology, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Figure 21: Immunohaematology, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 59
Figure 22: Haemostasis, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 60
Figure 23: Haemostasis, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 62
Figure 24: Haematology Rapid Tests, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 64
Figure 25: Haematology Rapid Tests, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 65
Figure 26: Haematology Cell Counters, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 66
Figure 27: Haematology Cell Counters, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Figure 28: Haematology, South Africa, Company Share (%), 2008 69
Figure 29: Histology And Cytology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 70
Figure 30: Histology And Cytology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 71
Figure 31: Histology, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 72
Figure 32: Histology, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 73
Figure 33: Histology And Cytology, South Africa, Company Share (%), 2008 75
Figure 34: Immuno Chemistry, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 76
Figure 35: Immuno Chemistry, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Figure 36: Disease Specific Immunochemistry, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 80
Figure 37: Disease Specific Immunochemistry, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Figure 38: Drug Related Testing, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 84
Figure 39: Drug Related Testing, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 85
Figure 40: Endocrinology Tests, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 86
Figure 41: Endocrinology Tests, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 87
Figure 42: Immunochemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 88
Figure 43: Immunochemistry Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Figure 44: Immuno Chemistry, South Africa, Company Share (%), 2008 93
Figure 45: Infectious Immunology, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 95
Figure 46: Infectious Immunology, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 97
Figure 47: Infectious Immunology, South Africa, Company Share (%), 2008 100
Figure 48: Microbiology Culture, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2008 102
Figure 49: Microbiology Culture, South Africa, Revenue ($ mn) by Segment, Forecast, 2008-2015 104
Figure 50: Microbiology Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 106
Figure 51: Microbiology Analyzers, South Africa, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 107
Figure 52: Microbiology Culture, South Africa, Company Share (%), 2008 109
Figure 53: Global Markets Direct Methodology 143

Companies Mentioned
Ventana Medical Systems, Inc.
Sysmex Corporation
Siemens Healthcare
Qiagen N.V.
Phadia AB
Ortho-Clinical Diagnostics Inc.
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Hologic, Inc.



Gen-Probe Incorporated
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A
Dade Behring Holdings, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Beckman Coulter, Inc.
Abbott Laboratories



Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information
Please verify that the product information is correct and select the format(s) you require.

South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Product Formats
Please select the product formats and the quantity you require.

1 User License--USD 2 500.00 Quantity: _____

Site License--USD 5 000.00 Quantity: _____

Corporate License--USD 7 500.00 Quantity: _____

Contact Information
Please enter all the information below in BLOCK CAPITALS

Title: Mr Mrs Dr Miss Ms Prof

First Name: _____________________________ Last Name: __________________________________

Email Address: __________________________________________________________________________

Job Title: __________________________________________________________________________

Organization: __________________________________________________________________________

Address: __________________________________________________________________________

City: __________________________________________________________________________

Postal / Zip Code: __________________________________________________________________________

Country: __________________________________________________________________________

Phone Number: __________________________________________________________________________

Fax Number: __________________________________________________________________________



Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card Card Number: ______________________________________________

Expiry Date __________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms

Please fax this form to:

Europe, Middle East and Africa : + 33 4 37 37 15 56

Asia, Oceania and America : + 1 (805) 617 17 93


South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (15)

More from ReportLinker.com

More from ReportLinker.com (20)

Recently uploaded

Recently uploaded (20)

South Africa In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015